Fungal Keratitis
10
1
1
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
20.0%
2 terminated out of 10 trials
75.0%
-11.6% vs benchmark
40%
4 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (10)
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)
Collagen Cross-linking in Infectious Keratitis Trial
A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine